INHALED DRY POWDER BUDESONIDE
Clinical Indication
Covid 19 treatment
Date of classification
April 2021
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.